It has been highlighted that global biotechnology and pharmaceutical companies are looking up to Singapore to set up their first-in-Asia manufacturing facilities and headquarters offices as they plan to capitalise on opportunities in this region.Fixed asset investments from biomedical companies exceeded US$800 million in 2009.
According to Singapore Economic Development Board (EDB), even though Asia’s growth presents attractive opportunities, its diversity also poses challenges. Full Story
